Back
Grace Therapeutics Stock Price Chart
Sponsored
GRCE
Sponsored
How to Turn the AI Energy Crisis into BIG Profits
And investors who move now into one technology could make a whole lot of money.
Buy
52
GRCE
Grace Therapeutics
Last Price:
$3.88
Seasonality Move:
12.25%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRCE is experiencing selling pressure, which indicates risk of future bearish movement.
Grace Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.84 | Sell |
20-day SMA: | 3.77 | Buy |
50-day SMA: | 3.44 | Buy |
200-day SMA: | 3.04 | Buy |
8-day EMA: | 3.87 | Sell |
20-day EMA: | 3.75 | Buy |
50-day EMA: | 3.48 | Buy |
200-day EMA: | 3.08 | Buy |
Grace Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 53.62 | Buy |
Chaikin Money Flow: | -26053 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.25 - 4.05) | Buy |
Bollinger Bands (100): | (2.52 - 3.56) | Buy |
Grace Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.83 while GRCE 8-day simple moving average is 3.84, which is a Sell signal.
-
The stock price of GRCE is 3.83 while Grace Therapeutics 20-day SMA is 3.77, which makes it a Buy.
-
Grace Therapeutics 50-day simple moving average is 3.44 while GRCE share price is 3.83, making it a Buy technically.
-
GRCE stock price is 3.83 and Grace Therapeutics 200-day simple moving average is 3.04, creating a Buy signal.
GRCE Technical Analysis vs Fundamental Analysis
Buy
52
Grace Therapeutics (GRCE)
is a Buy
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a BuyThe current Grace Therapeutics [GRCE] share price is $3.83. The Score for GRCE is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Grace Therapeutics Stock Info
Market Cap:
38.8M
Price in USD:
3.83
Share Volume:
26.1K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.98
Buy
52
Grace Therapeutics (GRCE)
is a Buy
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 3.83 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is not overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 3.83 while GRCE 8-day exponential moving average is 3.87, which is a Sell signal.
-
The stock price of GRCE is 3.83 while Grace Therapeutics 20-day EMA is 3.75, which makes it a Buy.
-
Grace Therapeutics 50-day exponential moving average is 3.48 while GRCE share price is 3.83, making it a Buy technically.
-
GRCE stock price is 3.83 and Grace Therapeutics 200-day simple moving average is 3.08, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and an increase next year of $0.23 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.16, suggesting Grace Therapeutics is a Buy
-
Grace Therapeutics Relative Strength Index (RSI) is 53.62, which suggest Grace Therapeutics is overbought
-
The Bollinger Bands (25) for Grace Therapeutics is (3.25 - 4.05), which suggest Grace Therapeutics is a Buy
-
The Bollinger Bands (100) for Grace Therapeutics is (2.52 - 3.56), which suggest Grace Therapeutics is a Buy
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.